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ttp://dx.doi.org/10.1016/j.ajpath.2013.09.020Melanoma is a tumor where virulence is conferred on transition from ﬂat (radial) to three-dimensional
(tumorigenic) growth. Virulence of tumorigenic growth is governed by numerous attributes, including
presence of self-renewing stem-like cells and related formation of patterned networks associated with
the melanoma mitogen, laminin, a phenomenon known as vasculogenic mimicry. Vasculogenic mimicry
is posited to contribute to melanoma perfusion and nutrition in vivo; we hypothesized that it may also
play a role in stem celledriven spheroid formation in vitro. Using amodel of melanoma in vitro tumorigenesis,
laminin-associated networks developed in association with three-dimensional melanoma spheroids. Real-
time PCR analysis of laminin subunits showed that spheroids formed from anchorage-independent mela-
noma cells expressed increased a4 and b1 laminin chains and a4 laminin expression was conﬁrmed by in situ
hybridization. Association of laminin networks with melanoma stem celleassociated nestin and vascular
endothelial growth factor receptor-1 alsowas documented.Moreover, knockdownof nestin gene expression
impaired laminin expression and network formation within spheroids. Laminin networks were remarkably
similar to those observed in melanoma xenografts in mice and to those seen in patient melanomas. These
data indicate that vasculogenic mimicryelike laminin networks, in addition to their genesis in vivo, are
integral to the extracellular architecture of melanoma spheroids in vitro, where they may serve as stimu-
latory scaffolds to support three-dimensional growth. (Am J Pathol 2014, 184: 71e78; http://dx.doi.org/
10.1016/j.ajpath.2013.09.020)Supported by NIH grant SPORE 5P50CA093683-08, NIH grant
5R01CA138231-05, and BWH Biomedical Research Institute Microseed
grant. A.R.L. is supported by NIH Training grant T32AR007098-38.
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work on melanoma biomarkers that are unrelated to this work.Vasculogenic mimicry (VM) is a phenomenon that may be
observed in aggressive melanoma cell lines that contain
subpopulations of cells with an embryonic-like phenotype.1
First described by Maniotis, Hendrix, and colleagues in
1999,2 VM is deﬁned by expression of endothelial genes by
primitive tumor cells in association with net-like or tubular
patterns of extracellular matrix deposition.3,4 VM-like net-
works within melanoma are PAS-positive and, in patients,
are associated with poor prognosis independent of Breslow
depth.5,6 In addition to PAS positivity, laminin expression is
also an important biomarker associated with VM.1,7 Inhibi-
tion of the laminin g2 chain reduced the expression of vas-
culogenic mimicryeassociated genes in melanoma cells.8
Furthermore, when nonaggressive melanoma cells were
plated onto collagen matrices preconditioned with laminin
networks made by aggressive melanoma cells, they formed
tubules and networks along the existing laminin scaffolds.8
Genes involved in angiogenesis and vasculogenesis werestigative Pathology.
.up-regulated in aggressive melanoma cells.9 These included
vascular endothelial growth factor-C (VEGF-C), vascular
endothelial (VE)-cadherin (CD144), tyrosine kinase with Ig
and epidermal growth factor homology domains-1 (TIE-1),
the laminin-5 g2 chain, and ephrin-A2. The amount of
VE-cadherin and TIE-1 seen on Western blots was greater in
highly aggressive, as opposed to less aggressive, melanoma
cell lines.10 CD31 was not present. Melanoma cells with
Larson et alVE-cadherin knockdown lost the ability to form VM-like
networks,10 implicating their crucial role in VM.
We have previously conﬁrmed laminin chain b2 networks
in melanoma xenografts to be dependent on expression of
vascular endothelial growth factor receptor-1 (VEGFR-1)
by stem-like melanoma cells that coexpress endothelial
markers VE-cadherin and TIE-1, but not CD31.11 VM, as
described by Hendrix and colleagues,1,3 may be promoted
by a hypoxia-driven in vivo pathway whereby aggressive
cancer cells contribute to perfusion during periods of rapid
growth via true anastomoses with authentic tumor vessels or
by transporting ﬂuid from sites of intralesional vascular
leakage.12,13
Laminin is a heterotrimeric protein composed of various
combinations of one of ﬁve a, three b, and three g subunits.
Laminin serves as an important basement membrane pro-
tein, with laminin 411 (a4, b1, g1) involved in formation of
vascular basement membranes. Various laminin isoforms
are expressed by melanoma cell lines and patient mela-
nomas.8,14,15 Throughout this paper, unless a speciﬁc lam-
inin chain or heterotrimer is designated, we use laminin as a
generic term for the protein family or when the speciﬁc
laminin isoforms are unknown. Moreover, studies have
implicated a correlation between laminin expression and
melanoma virulence, although the biological basis for this
association remains conjectural. It is known, however, that
extracellular laminin (either secreted by keratinocytes,
endothelial cells, or added exogenously) promotes mela-
noma mitogenesis, growth, and migration.16e20 Indeed,
particular regions within laminin chains have been found to
enhance melanoma metastasis to organs such as lung and
liver.21,22
In this study, we used melanoma spheriods as a model for
three-dimensional tumorigenesis in an effort to study
laminin-associated VM.23e26 Although previous pioneering
work has established the ability of several melanoma cell
lines to produce VM on radial proliferation on laminin gels,2
examination of three-dimensional models that recapitulate
the expansile tumorigenic growth phase of melanoma is
lacking. Melanoma spheroids have been used as assays for
stem cell activity and have been implicated in melanoma
self-renewal and tumorigenesis.27,28 We hypothesized that
not only is VM integral for melanoma nutrition and perfu-
sion but also plays an important role in stem celledriven
spheroid formation, a potential three-dimensional in vitro
surrogate for early tumorigenic growth. The data presented
support this hypothesis and establish melanoma spheroids as
a novel model for exploring the pathobiology of VM.
Materials and Methods
Cell Lines and Cell Culture
Human melanoma cell A2058 and A375 were originally
obtained from American Type Culture Collection (Mana-
ssas, VA). Melanoma cells were grown in Dulbecco’s72modiﬁed Eagle’s medium (Sigma-Aldrich, St. Louis, MO)
supplemented with 10% heat-inactivated fetal bovine
serum (Hyclone Laboratories, Logan, UT) and 200 mmol/L
L-glutamine, 100 IU/mL penicillin, and 100 mg/mL strep-
tomycin, and maintained at 37C, 5% CO2. Viable cells
were counted by Trypan blue exclusion assay under a
hemocytometer.
Melanoma Spheroid Cultures
Liqueﬁed Matrigel (50 mL; Millipore, Billerica, MA) was
spotted onto a Petri dish and allowed to set at 37C for 2
hours; 5  103 A2058 viable cells per 10 mL complete me-
dium were loaded over Matrigel, incubated at 37C, 5% CO2,
for 4 hours for attachment, and then overlaid with complete
medium and cultured for 7 to 10 days. Melanoma spheroids
over Matrigel were ﬁxed with formalin and embedded.
Perpendicular sections were used for histological analysis.
Melanoma spheroid culture in suspension was performed
at low cell-plating density (2000 viable cells per 6-well or
1000 viable cells per 24-well) in Dulbecco’s modiﬁed Ea-
gle’s medium supplemented with 10% fetal bovine serum
and penicillin/streptomycin/glutamine in the ultra-low
attachment plate (Corning, Acton, MA) at 37C containing
5%CO2 for 14 to 21 days. Spheroids were fed with 0.5 mL of
fresh medium twice weekly. They were collected, ﬁxed, and
processed for histological analysis using a Cellient Auto-
mated Cell Block System (Hologic, Marlborough, MA).
Epithelial growth factor and ﬁbroblast growth factor-2 were
not used for Matrigel or suspension cultures because they
may alter nestin expression.29,30 Methylcellulose was used in
the media for all spheroid cultures to prevent aggregation.31
shRNA Gene Knockdown
A lentivirus-based shRNA method was used to knock
down the gene expression of nestin. shRNA clones
(TRCN000014728, TRCN000014729, TRCN000014730,
TRCN000014731, and TRCN000014732) speciﬁcally tar-
geting nestin were purchased (Sigma-Aldrich). shRNA
lentivirus was produced in HEK293T cells by cotransfecting
shRNA lentiviral backbone and packaging vectors psPAX2,
pMD2.VSV-G as described before.32 Supernatant was
collected and ﬁltered through 0.45-mm ﬁlters and used to
transfect target cells. A nontargeting, scramble vector
(SHC002; Sigma-Aldrich) was used as vector control.
Efﬁcacy of nestin gene knockdown (nestin KD) was
conﬁrmed by quantitative real-time PCR and Western blot.
Among the ﬁve shRNA clones examined, TRCN000014728,
which targeted the 30-untranslated region of nestin, had the
highest KD efﬁciency and was routinely used in this study.
Quantitative Real-Time RT-PCR
Total RNA from A2058 adherent cells and spheroid-
forming cells, including nestin KD and vector controls,ajp.amjpathol.org - The American Journal of Pathology
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CA). cDNA was reverse transcribed from total RNA using
the SuperScript III First-Strand Synthesis System (Invi-
trogen, Carlsbad, CA). Relative expression of each of the
eight laminin a and b chain isoforms were compared be-
tween the spheroid-forming and adherent cells using real-
time RT-PCR Applied Biosystems 7300 system (Foster
City, CA) and the 2DDCt method of analysis33 with >2-fold
changes considered signiﬁcant. Similarly, nestin expression
was analyzed in the nestin KD and vector control spheroids
compared to glyceraldehyde 3-phosphate dehydrogenase.
The primers of laminin chains a1, a3 to a5, and b1 to b3, as
seen in Table 1, were ordered for SyBr Green real-time
PCR, partly based on the sequences of Oikawa et al.14
TaqMan real-time PCR primers of human nestin
(Hs00707120_s1), matrix metalloproteinase 2 (MMP2)
(Hs01548727), and laminin a2 (Hs01124081_m1) were
purchased from Applied Biosystems.
Western Blot Analysis
Subconﬂuent cell cultures and medium were collected for
Western blot analysis. Cells were resuspended in cell lysate
buffer (Cell Signaling, Danvers, MA) containing proteinase
inhibitor and phenylmethylsulfonyl ﬂuoride. Cell lysate
protein (100 mg) and 50 mL of cell culture medium (cell con-
centration of 2  105/mL) were loaded onto SDS-PAGE gel
along with molecular weight markers. Proteins were separated
at a constant 100 V for 3.5 hours and transferred to a nitro-
cellulose membrane at a constant 340mA for 1.5 hours at 4C.
The membrane was blocked with 5% nonfat milk in Tris-
buffered salineeTween 20 at room temperature for 1 hour,
incubated with primary nestin antibody at 1:1000 dilution at
4C overnight, and incubated with horseradish peroxidasee
conjugated secondary antibodies at room temperature for 1
hour with actin as the loading control. Signal was developed
using chemiluminescent substrate (Thermo Scientiﬁc, Rock-
ford, IL) at room temperature for 5 minutes and detected
by ﬁlm. Antibodies for Western blot analysis were commer-
cially available for mouse anti-nestin (#AB5922; Millipore),
and mouse anti-actin (#ab6276; Abcam, Cambridge, MA).
Immunohistochemistry
Immunohistochemical studies used 5-mm sections of
formalin-ﬁxed, parafﬁn-embedded tissue. All slides wereTable 1 Laminin Primer Sequences
Laminin Forward
alpha 1 50-CAGACTTTGGATGAAGATTTCC-
alpha 3 50-AGTCGACTAAGTTTCCCTCC-30
alpha 4 50-CTGGATCAGCTTCGTACGGT-30
alpha 5 50-AACAACTTCGCCGAGGGCTG-30
beta 1 50-CAGCAGCTTCTGAGGAAACC-30
beta 2 50-TGGCTTCTTTGGGCTCAGCA-30
beta 3 50-CGGGCTGCGACAAGGCATCA-30
The American Journal of Pathology - ajp.amjpathol.orgdeparafﬁnized and rehydrated, and for laminin staining,
underwent antigen retrieval with 60 mg/mL proteinase K at
37C for 30 minutes. For the remaining antibodies, heat-
based antigen retrieval was performed in citrate buffer.
Sections were incubated with primary antibody at 4C
overnight and then incubated with peroxidase-conjugated
goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA)
at room temperature for 60 minutes, followed by detection
with NovaRED Substrate (Vector Laboratories) for nonﬂu-
orescent immunohistochemistry. For immunoﬂuorescent
staining, slides were incubated with Alexa Fluor 594
donkey anti-goat IgG and Alexa Fluor 488 donkey anti-
rabbit IgG secondary antibodies at room temperature for
60 minutes. Rabbit anti-human polyclonal laminin (1:7500)
(#Z0097; Dako, Carpinteria, CA), rabbit anti-human nestin
(1:1000) (#5326; Millipore), rabbit anti-human VE-cadherin
(1:20) (#2500; Cell Signaling Technology, Beverly, MA),
rabbit anti-human CD31 (1:100) (#00055; Bethyl, Mont-
gomery, TX), and goat anti-human VEGFR-1 (1:20)
(#AF321; R&D Systems, Minneapolis, MN) primary anti-
bodies were used.
In Situ Hybridization
Laminin RNA probes were prepared with the primer pair 50-
TAATACGACTCACTATAGGGA-30 and 50-CCCGCAG-
TTGCACACTGCACAG-30, and used to generate the DNA
template for antisense and sense RNA probes spanning 282
bp of human laminin a4 cDNA. RNA probe labeling with
digoxigenin and in situ hybridizations were performed as
previously described.34
Melanoma Xenografts
NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice were pur-
chased from The Jackson Laboratory (Bar Harbor, ME).
Mice were maintained in accordance with the institutional
guidelines of Harvard Medical School, and experiments
were performed according to the approved experimental
protocols. Human to mouse melanoma xenografts were
performed as described11 with injection of 103 to 104 A375
melanoma cells into NSG mice.
Patient Melanomas
Eleven human melanomas (ﬁve radial growth phase and six
vertical growth phase) were obtained from the PathologyReverse
30 50-AGTTCAAGGGTGGCATTTTG-30
50-CAAGGCTCCACTTCAGTTGTG-30
50-GAGACTTGGATCTTGCTGGC-30
50-AGTGGGTTCCCAAAGAATCC-30
50-CAATATATTCTGCCTCCCCG-30
50-ACTGTTGGGGTCACAAGGAG-30
50-CACCGGGTAGCGATTACAGTA-30
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Figure 1 Laminin immunohistochemistry of developing melanoma A2058 spheroids (A) grown on laminin-containing Matrigel matrices (m) shows pro-
gressive development of internal patterned networks and small lumen-like spaces (region enclosed by the box is enlarged in B). Laminin also formed a mantle
that enveloped the spheroids (arrows) and that appeared to associate with budding of minispheroids into the culture suspension (A, arrows). A2058 and A375
melanoma spheroids grown free in suspension also exhibited immunohistochemical laminin networks (C, arrows), unlike single adherent melanoma cells (D).
RT-PCR of speciﬁc laminin a and b subunit chains conﬁrmed that A2058 melanoma spheroid-forming cells expressed a different laminin subunit proﬁle from
A2058 melanoma adherent cells with increased expression of the a4 and b1 chains (E). In situ hybridization for the laminin a4 chain mRNA on A2058
melanoma spheroids conﬁrms this ﬁnding (F, arrows indicate laminin expression). Asterisks indicate a greater than twofold increase in expression. Original
magniﬁcation: 400 (A and F); 1600 (B, C, and D).
Larson et alArchives of Brigham and Women’s Hospital. The radial
growth phase lesions were all Clark levels I and II, and the
vertical growth phase lesions were all Clark levels III and
IV. Patient samples were obtained with approval from the
institutional review board of Brigham and Women’s
Hospital.
Results
Melanoma spheroids derived from both A2058 and A375
cell lines formed within 2 weeks from cells growing on
Matrigel and within 3 weeks from suspension cultures.74Matrigel-associated spheroids appeared to develop from
small aggregates of cells that progressively proliferated
along three-dimensional planes (Figure 1A). Laminin
staining (Figure 1) revealed variably complex patterned
networks within Matrigel-associated spheroids (Figure 1, A
and B) as well as in spheroids derived from suspension
culture (Figure 1C). By contrast, adherent cells not grown
on Matrigel failed to form spheroids or stain positively for
detectable laminin by immunohistochemistry (Figure 1D).
RT-PCR of laminin subunits conﬁrmed that A2058
Matrigel-derived spheroids expressed a different laminin
subunit mRNA proﬁle from nonespheroid-forming adherentajp.amjpathol.org - The American Journal of Pathology
Melanoma Spheroid Vasculogenic Mimicrycells (Figure 1E). Speciﬁcally, spheroid-forming cells
showed a greater than twofold increase in laminin chains a4
and b1. Laminin a4 production by spheroids was further
conﬁrmed by in situ hybridization with a probe speciﬁc for
the laminin a4 subunit (Figure 1F).
H&E evaluation of Matrigel-associated spheroids revealed
occasional foci of lumen-like formations (Figure 2A). These
lumen-like structures consisted of circular to ovoid zones
lined by a laminin-positive mantle (Figure 2B) that was
focally continuous with laminin networks (Figure 1B) and
stained positively for the vasculogenesis and stem-
celleassociated biomarker nestin (Figure 2C), as well as for
VE-cadherin (Figure 2D), whereas the mantle stained nega-
tively for CD31 (not shown). VEGFR-1 and laminin
immunoﬂuorescence double labeling required steam antigen-
retrieval and revealed colocalization of these two markers in
cell cords with evidence of cytoplasmic laminin not generally
appreciated by immunohistochemistry with proteinase K
antigen retrieval (Figure 2, EeH). Overall, laminin-positive
networks in spheroids were similar to those seen in mouseFigure 2 H&E staining of spheroids shows lumen-like spaces (A) that stain pos
angiogenesis/vasculogenesis markers nestin (C), VE-cadherin (D, arrows indicate
skin), and VEGFR-1, whose expression overlaps with laminin by ﬂuorescent immu
immunohistochemical laminin networks seen in melanoma spheroids (I) are simi
arrows indicate laminin expression. Original magniﬁcation: 400 (AeK); 100
The American Journal of Pathology - ajp.amjpathol.orgmelanoma xenografts and in human melanomas (Figure 2,
IeK). Networks in patient melanomas were restricted to the
vertical growth phase of patient melanomas and were
detected in only 17% of vertical growth phase lesions
examined.
To assess depletion of a known melanoma stem
celleassociated marker, nestin,35 on laminin network for-
mation, we evaluated the effects of nestin gene KD on
spheroid laminin network formation by the A2058 mela-
noma cell line (Figure 3). Nestin KD was conﬁrmed by RT-
PCR (Figure 3A) and Western blotting (Figure 3B). For
most laminin chains, including a4 and b1, there was
increased expression in vector control cells compared to KD
cells (Figure 3C). As compared to wild-type controls, nestin
KD immunohistochemistry (Figure 3, D and E), showed
markedly diminished to absent formation of laminin net-
works in size-matched spheroids (Figure 3, F and G).
Because tubular structures were an infrequent ﬁnding in
the wild-type spheroids, it was difﬁcult to tell whether there
was a marked change in these structures on nestin KD.itively for laminin by immunohistochemistry (B, arrows) and the associated
positive expression, inset is a VE-cadherin stain of a blood vessel in normal
nohistochemistry (VEGFR-1, E; laminin, F; DAPI, G; merged image, H). The
lar to those seen in melanoma xenografts (J) and patient melanomas (K);
(inset).
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Figure 3 Nestin KD A2058melanoma cells show a decrease in nestin RNA
by PCR (A) and protein by Western blot (B). Vector control melanoma cells
show increased expression of multiple laminin chains, including a4 and b1;
a2 and a4 are signiﬁcantly increased compared to nestin KD (C). Similarly
sized spheroids show increased nestin expression by immunohistochemistry
in vector controls (D) compared to nestin KD spheroids (E) and have well-
formed laminin mantles in controls (F, arrows) compared to poorly formed
wispy laminin networks in nestin KD (G, arrows). Asterisks indicate greater
than twofold increase in expression. Original magniﬁcation: 400 (DeG).
Larson et alAdditionally, nestin KD did not alter MMP2 mRNA
expression in A2058 melanoma cells (data not shown).
Discussion
In this study, we demonstrated that: i) laminin networks
resembling VM develop in melanoma spheroids in vitro;
ii) spheroids with laminin networks and lumen-like structures
contain subpopulations of cells that preferentially express
VM and stem celleassociated biomarkers VE-cadherin,
VEGFR-1, and nestin; iii) KD of the melanoma stem cell
biomarker nestin diminishes laminin network formation; and
iv) spheroid laminin networks are morphologically similar to
xenograft and patient melanoma networks.76It has been well known since the 1980s that certain mela-
noma cell lines, or subpopulations of cells within these cell
lines, form spheroids in vitro.36 Melanoma formation of
spheroids is believed by many to serve as a model for a sub-
population of self-renewing stem-like melanoma cells
that through asymmetrical division produce cellular diversity
during three-dimensional tumorigenesis akin to the nodular
vertical growth phase of melanoma in vivo.25,26,37,38 Mela-
noma spheroids exhibit more chemoresistance than their
counterparts that grow in monolayers,26,39 and this charac-
teristic is considered to further reﬂect stem cellelike
behavior.25,38 However, spheroids are not universally
accepted as a system with pure clonally derived colonies, and
there is a debate regarding the use of spheroids as a model
system for stem cellelike tumorigenesis.31,40 In theory,
spheroids could also arise from cellecell aggregation,
although in our hands, melanoma spheroids preferentially
express stem cell markers (unpublished data), and methyl-
cellulose is regularly used to prevent aggregation.31 The ten-
dency of melanoma cells to form spheroids may also be due to
the microenviroment in which they are grown.41,42 Cancer
spheroids are known to form preferentially in association with
Matrigel, and this was also true in the present study for A2058
melanoma cells.43 In one study, when Matrigel was injected
along with melanoma cells into NOD/SCID mice, the mela-
noma cells had a higher growth rate and showed increased
tumorigenicity.44Matrigel contains structural proteins such as
laminin, a knownmelanomamitogen,16e20 as well as collagen
and other growth factors.45 Laminin subunit b2 has recently
been shown to be produced in human melanoma xenografts
where it is intimately associated with stem-like cells.11 The
capability of generating laminin networks by melanoma
spheroids, both associated and unassociated with Matrigel,
and the spatial relationship of these networks to stem-like cells
further emphasizes the potential interdependence of stem
celledriven three-dimensional melanoma growth and key
mediators in the extracellular microenvironment. Although
MMP2 has been shown to be indispensable for VM,8 in our
study, expression of stem celleassociated nestin appeared to
be required for VM formation, prompting ongoing inquiry
into potential biological interplay between nestin and MMP
gene expression (unpublished data). Nestin has been shown to
be related to other stem-like cell marker pathways that are
associated with VM, speciﬁcally Notch4/Nodal and cyclic
adenosine monophosphate (cAMP)/exchange protein acti-
vated by cAMP (Epac)/Ras related protein 1 (Rap1). Notch4
and Nodal have been found to be associated with VM and
aggressive behavior in melanoma cells,46 murine xenografts
and patient melanomas.34 Nodal inhibition is associated with
up-regulation of nestin in embryonic stem cells, implying a
relationship between these proteins. The cAMP/Epac/Rap1
pathway inhibits VM in melanoma cells,47 although individ-
ually, cAMP48 and Rap149 may increase nestin expression.
Thus, although nestin expression appears to impact on path-
ways that inﬂuence VM formation, the complexity of these
interactions will require further study.ajp.amjpathol.org - The American Journal of Pathology
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ﬂuid transport, and nutrition, all critical requirements at early
stages of invasive melanoma tumorigenesis when expansile
intradermal growth may not be fully supported by conven-
tional angiogenesis. However, the spheroidmodel is an in vitro
surrogate for tumorigenic growth devoid of dependency on
angiogenesis. Accordingly, laminin networks within mela-
noma spheroids could provide insight into an additional
beneﬁt of VM, namely provision of a three-dimensional
stimulatory scaffold to support tumorigenic growth.
We noted increased expression of laminin chains a4 and
b1 in melanoma spheroids. Laminin 411 is typically
expressed in the basement membrane of blood vessels,
consistent with VM-like activity by spheroid-forming cells.
This notion is further substantiated by biomarkers indicative
of expression of endothelial and stem cellerelated proteins.
In contrast to melanoma spheroids, it may be difﬁcult to
distinguish whether the laminin in VM within human mela-
nomas and melanoma xenografts is derived from endothelial
cells, adjacent keratinocytes, or melanoma cells per se.
Accordingly, melanoma spheroids, particularly when unas-
sociated with Matrigel, provide novel insight into the biology
of VM-like network formation and now provide a model for
further elucidation of this phenomenon. It is interesting that
different laminin chains and heterotrimers have been found to
be expressed by different melanoma cell lines and patient
samples.8,14,15 Thus, there seems to be heterogeneity in the
subsets of laminin proteins involved in VM in melanoma.
In our experience, laminin network expression by advanced
primary cutaneous melanomas in patients is not a ubiquitous
ﬁnding. Indeed, of six vertical growth phase lesions in this
study, only one showed striking network formation. Most
melanomas begin as a superﬁcial growth phase closely
associated with the laminin-rich dermaleepidermal junction.
In this phase, cells proliferate radially along an extrinsic
laminin gradient produced predominantly by basal keratino-
cytes.50 Invasive cells eventually acquire the capacity to grow
within the dermis vertically in three-dimensional spherical
nodules. During early phases of this vertical (tumorigenic)
growth before the ingrowth of authentic vessels, metabolic
factors [eg, hypoxia-inducible factor 1a (HIF-1a)] drive
VM.51 This scenario could explain why some established
invasive cutaneous melanomas, replete with networks of
authentic tumor vessels and evolving over many months to
years, may show a paucity of residual VM-like laminin net-
works, although these networks are easily detected in human
melanoma xenografts11 that grow rapidly over several weeks.
The ability to study laminin networks and the cells that pro-
duce them in spheroids will hopefully now provide trans-
lational insights into the roles of VM in patient melanomas.
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